BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2009 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Cramer on BloggingStocks: Sanofi has lots of upside catalysts ]]>http://www.bloggingstocks.com/2009/11/23/cramer-on-bloggingstocks-sanofi-has-lots-of-upside-catalysts/http://www.bloggingstocks.com/2009/11/23/cramer-on-bloggingstocks-sanofi-has-lots-of-upside-catalysts/http://www.bloggingstocks.com/2009/11/23/cramer-on-bloggingstocks-sanofi-has-lots-of-upside-catalysts/#commentsFiled under: , , , , , , , ,

TheStreet.com's Jim Cramer says it looks like the patent worries aren't so dire after all.

Now that we see that health care reform is not going to bring price caps or socialization of medicine, we are beginning to see some real expansion in the drug stocks, including Merck (MRK) (Cramer's Take), Bristol-Myers (BMY) (Cramer's Take) and Lilly (LLY) (Cramer's Take). But there is one drug stock that is continually met with skepticism -- Sanofi Aventis (SNY) (Cramer's Take), the French vaccine and pharmaceutical maker run by Christian Viehbacher. The resistance is obvious, as his biggest two drugs are coming off patent very soon, and his hope is that by 2013 the company might again reach 2008 levels.

Sounds like there's no reason to buy this one. Sounds like its 4% dividend isn't safe.

Continue reading Cramer on BloggingStocks: Sanofi has lots of upside catalysts

Cramer on BloggingStocks: Sanofi has lots of upside catalysts originally appeared on BloggingStocks on Mon, 23 Nov 2009 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Christian ViehbacherChristianViehbacherfeaturedjim cramerJimCramermonplavixsanofi-aventissnyMon, 23 Nov 2009 10:00:00 EST<![CDATA[Chasing Value: Ten stocks for 2010 -- Part 2]]>http://www.bloggingstocks.com/2009/11/12/chasing-value-ten-stocks-for-2010-part-2/http://www.bloggingstocks.com/2009/11/12/chasing-value-ten-stocks-for-2010-part-2/http://www.bloggingstocks.com/2009/11/12/chasing-value-ten-stocks-for-2010-part-2/#commentsFiled under: , , , , , , , , , , , , , ,

The clock is ticking away the time before the year ends and I have only begun to sort out the possibilities. In Part 1 of this series, I discussed breaking up my potential picks into three categories: contender, on the fence, and out of the running until the 10 stocks have been identified.

Four contenders have been considered so far: American Eagle Outfitters (AEO), Anadarko Petroleum (APC), Anglo American ADR (AAUKY) and Diageo plc (DEO).

Six more are included in today's review: EZCorp Inc. (EZPW), General Electric Company (GE), Wells Fargo & Company (WFC), Annaly Capital Management ( NLY), Intuitive Surgical Inc (ISRG) plus Berkshire Hathaway (BRK.B). These include the remaining five from 2009 and one more familiar to most investors.

Continue reading Chasing Value: Ten stocks for 2010 -- Part 2

Chasing Value: Ten stocks for 2010 -- Part 2 originally appeared on BloggingStocks on Thu, 12 Nov 2009 15:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>2010 stock picks2010StockPicksannalycapitalmanagementberkshire hathawayBerkshireHathawayBNIBRK.ABRK.Bburlington northernBurlingtonNorthernchasing valueChasingValueezcorpEZPWfeaturedGEgeneral electricGeneralElectricGSintuitive surgicalIntuitiveSurgicalISRGNLYsheldon liberSheldonLiberwells fargoWellsFargoWFCThu, 12 Nov 2009 15:00:00 EST<![CDATA[Quick opinions on some quarterly earnings: AXP, MRK, MCD, NYT, UP ...]]>http://www.bloggingstocks.com/2009/10/25/quick-opinions-on-some-quarterly-earnings-axp-mrk-mcd-nyt-u/http://www.bloggingstocks.com/2009/10/25/quick-opinions-on-some-quarterly-earnings-axp-mrk-mcd-nyt-u/http://www.bloggingstocks.com/2009/10/25/quick-opinions-on-some-quarterly-earnings-axp-mrk-mcd-nyt-u/#commentsFiled under: , , , , , , , ,

A lot of earnings reports were issued last week. The market was busy sorting them all out. I'm going to take a fast look at several of the issuing companies.

American Express (NYSE: AXP): Don't leave home without it. Good advice for the card, perhaps, but what about the company? Should your portfolio leave home and forget this stock? I'd say so. It's not that American Express lost the earnings game. On the contrary, Bloomberg reported a beat. American Express earned 44 cents per share from continuing operations, adjusted. This was six pennies ahead of forecasts. Okay, I applaud such performance. And shares are way off the single-digit 52-week low. Thing is, I'm in love with another card business. Visa (NYSE: V). As I've stated before, I enjoy the beauty of Visa's lower-risk model. It doesn't have to put up with loan risk. Yes, the situation at American Express might be improving, but I'm not going to buy this one.

Continue reading Quick opinions on some quarterly earnings: AXP, MRK, MCD, NYT, UP ...

Quick opinions on some quarterly earnings: AXP, MRK, MCD, NYT, UP ... originally appeared on BloggingStocks on Sun, 25 Oct 2009 10:20:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>american expressAXPCSXEMCinthenewsMCDmcdonaldsMerckMRKnew york timesNYTraytheonRTNschering-ploughSGPunion pacificUnionPacificUNPVVisaSun, 25 Oct 2009 10:20:00 EST<![CDATA[Where should granny put $50,000?]]>http://www.bloggingstocks.com/2009/10/09/where-should-granny-put-50-000/http://www.bloggingstocks.com/2009/10/09/where-should-granny-put-50-000/http://www.bloggingstocks.com/2009/10/09/where-should-granny-put-50-000/#commentsFiled under: , , , , , , , , , , , , , , , , ,

One of my wonderful friends, Ms. P, asked me for some guidance on how she might allocate $50,000 currently earning peanuts in a money market account. Though she is decades from becoming a grandmother, after a brief discussion about her financial parameters, it became clear to me that she was looking for a "granny fund."

In reality, my recommendations would be suitable, and perhaps desirable, for many passive investors as well.

The $50,000 is a portion of money Ms. P has set aside to purchase a home, which might happen in six months, but could also be pushed out further, depending on the economy and her situation. Basically, she wants to cover all her bases because she might need the money at any time and does not want to be caught short, while at the same time she would like to generate some revenue without taking any big risks.

Continue reading Where should granny put $50,000?

Where should granny put $50,000? originally appeared on BloggingStocks on Fri, 09 Oct 2009 15:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>ADPaltriaannalycapitalmanagementautomatic data processingAutomaticDataProcessingBNDCondsolidated EdisonCondsolidatedEdisonDEOdiageo plcDiageoPlcDUKdukeEDfeaturedgeneral millsGeneralMillsGISJNJjohnsonandjohnsonKkelloggsMCDmcdonaldsmerckMOMRKNLYnovartisNVSPGprocter and gambleProcterAndGamblesheldon liberSheldonLiberSOsouthern companySouthernCompanyVanguardFri, 09 Oct 2009 15:40:00 EST<![CDATA[Dogs of the Dow: A look at five high yielders]]>http://www.bloggingstocks.com/2009/09/18/dogs-of-the-dow-a-look-at-the-5-higher-yielders/http://www.bloggingstocks.com/2009/09/18/dogs-of-the-dow-a-look-at-the-5-higher-yielders/http://www.bloggingstocks.com/2009/09/18/dogs-of-the-dow-a-look-at-the-5-higher-yielders/#commentsFiled under: , , , , , , ,

"The Dogs of the Dow strategy has a long-term history of outperforming the Dow Jones average," notes technical expert Gerald Appel.

In his Systems & Forecasts, he explains, "The theory is that the highest yielding stocks are undervalued and should have the greatest change of appreciating." Here, he reviews the five highest yielders.

"In calculating a formal track record for the strategy, dividend yields are ranked on the last trading day of each year. However, there is no reason why you are limited to ranking stocks only at the end of the year.

"The current market climate appears favorable for using this strategy to garner investment income, since market risk appears below normal and investment income is getting hard to come by.

Continue reading Dogs of the Dow: A look at five high yielders

Dogs of the Dow: A look at five high yielders originally appeared on BloggingStocks on Fri, 18 Sep 2009 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>attdddividend stocksdogs of the dowdow stocksdupongfeaturedforecasts straetegiesgerald appelhigh yielding stocksincome stockskftkraftmerckmrksteven halpernthestockadvisors.comverizonvzFri, 18 Sep 2009 10:00:00 EST<![CDATA[Options Update: Merck and Pfizer volatility low into pending acquisitions]]>http://www.bloggingstocks.com/2009/08/27/options-update-merck-and-pfizer-volatility-low-into-pending-acq/http://www.bloggingstocks.com/2009/08/27/options-update-merck-and-pfizer-volatility-low-into-pending-acq/http://www.bloggingstocks.com/2009/08/27/options-update-merck-and-pfizer-volatility-low-into-pending-acq/#commentsFiled under: , ,

Merck (NYSE: MRK) closed at $32.68. The Schering-Plough (NYSE: SGP) and Merck merger is expected to close before year end. SGP shareholders will receive 0.5767 shares and $10.50 in cash for each share of SGP. MRK October and January option implied volatility of 31 is below its 26-week average of 37, according to Track Data, suggesting decreasing price movement.

Pfizer (NYSE: PFE) closed at $16.77.Pfizer is expected to close on the acquisition of Wyeth (NYSE: WYE) for $33 in cash and 0.985 of a share of Pfizer by the end of 2009. PFE October option implied volatility is at 26, December is at 31; below its 26-week average of 36, according to Track Data, suggesting decreasing price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Options Update: Merck and Pfizer volatility low into pending acquisitions originally appeared on BloggingStocks on Thu, 27 Aug 2009 08:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>option implied volatilityOptionImpliedVolatilitypending acquisitionsPendingAcquisitionsSchering-PloughWyethThu, 27 Aug 2009 08:00:00 EST<![CDATA[Bellwether stock #8: Merck (MRK)]]>http://www.bloggingstocks.com/2009/08/02/bellwether-stock-8-merck-mrk/http://www.bloggingstocks.com/2009/08/02/bellwether-stock-8-merck-mrk/http://www.bloggingstocks.com/2009/08/02/bellwether-stock-8-merck-mrk/#commentsFiled under: , ,

bellwether stocks merckAlthough earnings for Merck (NYSE: MRK) were down in the last quarter, the stock is gaining momentum.

The pharmaceutical giant reported a 3% decrease in sales to $5.9 billion from $6.05 billion in the year-earlier period. Earnings were $1.56 billion or 74 cents per share, compared with $1.77 billion or 82 cents per share in the same quarter a year ago.

A strong dollar and lower sales for cholesterol and vaccine drugs contributed to Merck's decline this quarter. But investors were cheered by the fact that Merck reaffirmed its annual earnings forecast of $2.84 to $3.09 per share.

Continue reading Bellwether stock #8: Merck (MRK)

Bellwether stock #8: Merck (MRK) originally appeared on BloggingStocks on Sun, 02 Aug 2009 11:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>bellwether stockslouis navelliermerckMRKstocks to buytop stocksSun, 02 Aug 2009 11:00:00 EST<![CDATA[The real earnings story behind 10 bellwether stocks]]>http://www.bloggingstocks.com/2009/08/01/the-real-earnings-story-behind-10-bellwether-stocks/http://www.bloggingstocks.com/2009/08/01/the-real-earnings-story-behind-10-bellwether-stocks/http://www.bloggingstocks.com/2009/08/01/the-real-earnings-story-behind-10-bellwether-stocks/#commentsFiled under: , , , , , , , , , , , ,

bellwether stocksAlthough the headlines are screaming about how companies are beating their earnings estimates, little newsprint is being devoted to this quarter's real story.

That story is that revenues for many corporations are way down year over year, and more importantly, their top-line revenues are often coming in below Street estimates.

To be certain, there have been some real success stories so far in Q2, and we'll be talking about some of those in a moment. Moreover, it is always a good sign when companies beat their earnings estimates.

Continue reading The real earnings story behind 10 bellwether stocks

The real earnings story behind 10 bellwether stocks originally appeared on BloggingStocks on Sat, 01 Aug 2009 08:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>applecaterpillarcoca-coladupontfeaturedfordintellouis navelliermcdonaldsmerckstocks to buystocks to selltop stocksunited technologiesyahooSat, 01 Aug 2009 08:00:00 EST<![CDATA[Cramer on BloggingStocks: Copper inventory build threatens the cyclicals ]]>http://www.bloggingstocks.com/2009/07/29/cramer-on-bloggingstocks-copper-inventory-build-threatens-the-c/http://www.bloggingstocks.com/2009/07/29/cramer-on-bloggingstocks-copper-inventory-build-threatens-the-c/http://www.bloggingstocks.com/2009/07/29/cramer-on-bloggingstocks-copper-inventory-build-threatens-the-c/#commentsFiled under: , , , , , , , , , , , ,

TheStreet.com's Jim Cramer says the plunge in China overnight is being blamed on the industrial metal, so expect some carry-over.

It turns out copper was the metric. Drats, I thought it was the dollar or oil. I thought we were supposed to buy the cyclicals on earnings being better than expected. I thought we might be buying the minerals and the steels and the oils off the morning proxy of the Baltic Freight Index, known as the Baltic Fright Index in the days when it kept going down, and kept us out of the Freeports (NYSE: FCX) (Cramer's Take) and Vales (NASDAQ: VALE) (Cramer's Take) and Union Pacifics (NYSE: UNP) (Cramer's Take) and U.S. Steels (NYSE: X) (Cramer's Take).

Silly me.

Continue reading Cramer on BloggingStocks: Copper inventory build threatens the cyclicals

Cramer on BloggingStocks: Copper inventory build threatens the cyclicals originally appeared on BloggingStocks on Wed, 29 Jul 2009 10:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>bhpchkcopperesrxfcxfeaturedhsyjim cramerJimCramerjnjmomrkunpvalexWed, 29 Jul 2009 10:30:00 EST<![CDATA[Cramer on BloggingStocks: The health care bargain ]]>http://www.bloggingstocks.com/2009/07/27/cramer-on-bloggingstocks-the-health-care-bargain/http://www.bloggingstocks.com/2009/07/27/cramer-on-bloggingstocks-the-health-care-bargain/http://www.bloggingstocks.com/2009/07/27/cramer-on-bloggingstocks-the-health-care-bargain/#commentsFiled under: , , , , , , ,

TheStreet.com's Jim Cramer says health care has never been this cheap relative to the market in its history.

Health care's not done rallying. As President Obama prepared himself for claiming a great political victory, we are all recognizing that the single-payer, socialized medicine covering cradle-to-grave, 100% paid for by the rich, the fear that left all things health care in the P/E dustbin, is dead. That's not going to happen.

That leaves us with the biggest bargains the market has to offer.

Health care has never been this lowly valued relative to the market in its history. Remember, 98% of the time it trades at a meaningful premium. I think that many believe some of these moves (like the Celgene (NASDAQ: CELG) (Cramer's Take) move) is because of gigantic new drug finds. In fact, I think they just got too cheap and the only thing really meaningful about the Celgene rally came because one of its Revlimid studies was stopped for good results, actually a predictable event given how well the drug works on many different kinds of cancers.

Continue reading Cramer on BloggingStocks: The health care bargain

Cramer on BloggingStocks: The health care bargain originally appeared on BloggingStocks on Mon, 27 Jul 2009 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>abtbmycelgesrxfeaturedimajim cramerJimCramerjnjmhsmrkpfewlpMon, 27 Jul 2009 10:00:00 EST<![CDATA[Earnings highlights: Amazon, Coca-Cola, Ford, McDonald's, Merck, Starbucks ...]]>http://www.bloggingstocks.com/2009/07/26/earnings-highlights-amazon-coca-cola-ford-mcdonalds-merck/http://www.bloggingstocks.com/2009/07/26/earnings-highlights-amazon-coca-cola-ford-mcdonalds-merck/http://www.bloggingstocks.com/2009/07/26/earnings-highlights-amazon-coca-cola-ford-mcdonalds-merck/#commentsFiled under: , , , , , , , , , , ,

Here are some highlights from last week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Amazon, Coca-Cola, Ford, McDonald's, Merck, Starbucks ...

Earnings highlights: Amazon, Coca-Cola, Ford, McDonald's, Merck, Starbucks ... originally appeared on BloggingStocks on Sun, 26 Jul 2009 10:10:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>AmazonAMZNCALCoca-ColaContinentalearningsFordHasbroHersheyHSYJim CramerKimberley-ClarkKMBKOMCDMcDonaldsMerckMRKNetflixNFLXSBUXSingapore AirSINGFStarbucksTransformersUNHUnitedHealthSun, 26 Jul 2009 10:10:00 EST<![CDATA[Not much going on with Merck's Q2]]>http://www.bloggingstocks.com/2009/07/23/not-much-going-on-with-mercks-q2/http://www.bloggingstocks.com/2009/07/23/not-much-going-on-with-mercks-q2/http://www.bloggingstocks.com/2009/07/23/not-much-going-on-with-mercks-q2/#commentsFiled under: , , ,

Pharmaceutical company Merck (NYSE: MRK), whose colleagues include Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ), issued its Q2 numbers earlier in the week. Quite frankly, I found them to be boring. Of course, maybe boring isn't too bad these days, right? It's a lot better than an exciting ride on a profit-decline express.

Well, actually, Merck did see a decline in its bottom-line profit, but it wasn't an outrageously awful drop or anything like that. Merck made an adjusted 83 cents per share compared to an adjusted 86 cents per share in the comparable period. Three less pennies isn't the worst thing in the world on a relative basis. Plus, revenues increased 3% if you exclude currency effects (including them gives a decrease of 3%).

Continue reading Not much going on with Merck's Q2

Not much going on with Merck's Q2 originally appeared on BloggingStocks on Thu, 23 Jul 2009 10:40:00 EST. Please see our terms for use of feeds.

Read | Permalink | Email this | Comments]]>drug stocksDrugStocksinthenewsJNJjohnson and johnsonJohnsonAndJohnsonmerckMRKPFEPfizerpharmaceuticalsschering-ploughSGPThu, 23 Jul 2009 10:40:00 EST<![CDATA[Closing Bell: DJIA earnings mix it up (CAT, KO, DD, IBM, MRK, UNH, UTX)]]>http://www.bloggingstocks.com/2009/07/21/closing-bell-djia-earnings-mix-it-up-cat-ko-dd-ibm-mrk-un/http://www.bloggingstocks.com/2009/07/21/closing-bell-djia-earnings-mix-it-up-cat-ko-dd-ibm-mrk-un/http://www.bloggingstocks.com/2009/07/21/closing-bell-djia-earnings-mix-it-up-cat-ko-dd-ibm-mrk-un/#commentsFiled under: , , , , ,

Today's news boiled down to two issues. First was that five DJIA components reporting earnings this morning, with details on three components. The second issue was Ben Bernanke testifying that inflation was not a huge concern because the economy is likely to stay frail for some time. The markets were mixed to down most of the day until a late day rally saved shares.

Here were today's unofficial closing bell levels:

Dow 8,911.71 +63.56 (0.72%)
S&P 500 954.10 +2.97 (0.31%)
Nasdaq 1,914.13 +4.84 (0.25%)

Top 10 Analyst Upgrades/Downgrades

Continue reading Closing Bell: DJIA earnings mix it up (CAT, KO, DD, IBM, MRK, UNH, UTX)

Closing Bell: DJIA earnings mix it up (CAT, KO, DD, IBM, MRK, UNH, UTX) originally appeared on BloggingStocks on Tue, 21 Jul 2009 16:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>ben bernankeBenBernankeCATDDdjia componentsDjiaComponentsIBMKOMRKUNHUTXTue, 21 Jul 2009 16:00:00 EST<![CDATA[The safest dividend in the Dow]]>http://www.bloggingstocks.com/2009/07/07/the-safest-dividend-in-the-dow/http://www.bloggingstocks.com/2009/07/07/the-safest-dividend-in-the-dow/http://www.bloggingstocks.com/2009/07/07/the-safest-dividend-in-the-dow/#commentsFiled under: , , , , , , , , ,

"Following last year's dismal market performance, investors are looking for something they can be sure of in the year ahead; and for income investors, that means finding a safe and rewarding dividend yield," says Carla Pasternak.

In her High Yield Investing, she offers a fascinating review to find the "safest dividend in the Dow." Here's her assessment.

"The 30 members of Dow Jones Industrial Average represents some of the strongest names in America. So these corporate titans are a good place to start searching for the safest dividend.

"The first step in the process is not to look at the Dow at all, but to start with the 10-year Treasury note, currently yielding 3.86%.

Continue reading The safest dividend in the Dow

The safest dividend in the Dow originally appeared on BloggingStocks on Tue, 07 Jul 2009 12:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>carla pasternakdividend investingfeaturedhigh yield investingincome investingkftkraftthestockadvisors.comverizonvzyield investingTue, 07 Jul 2009 12:00:00 EST<![CDATA[Earnings preview: Will Pfizer beat in Q1? ]]>http://www.bloggingstocks.com/2009/04/27/earnings-preview-will-pfizer-beat-in-q1/http://www.bloggingstocks.com/2009/04/27/earnings-preview-will-pfizer-beat-in-q1/http://www.bloggingstocks.com/2009/04/27/earnings-preview-will-pfizer-beat-in-q1/#commentsFiled under: , , , , ,

Pfizer (NYSE: PFE), a pharmaceutical entity whose colleagues include Merck (NYSE: MRK), Novartis (NYSE: NVS), and Johnson & Johnson (NYSE: JNJ), will be reporting first-quarter earnings Tuesday. As one has come to expect, the market believes that the company will be experiencing a decline in bottom-line income. The call is for 49 cents per share versus 61 cents per share in the year-ago period.

That's a drop of 20%. That might not sound so hot, but the good news is that Pfizer has a solid recent track record when it comes to beating earnings expectations. So shareholders might be justified in feeling confident about that aspect of the game.

Continue reading Earnings preview: Will Pfizer beat in Q1?

Earnings preview: Will Pfizer beat in Q1? originally appeared on BloggingStocks on Mon, 27 Apr 2009 08:30:00 EST. Please see our terms for use of feeds.

Read | Permalink | Email this | Comments]]>earnings previewEarningsPreviewfeaturedJNJjohnson and johnsonJohnsonAndJohnsonMerckMRKnovartisNVSPFEPfizerpharmaceutical stockspharmaceuticalsPharmaceuticalStockssteven halpernStevenHalperntom taulliTomTaulliWYEWyethMon, 27 Apr 2009 08:30:00 EST<![CDATA[Earnings highlights: Bank of America, Amazon, Coke, eBay, UPS, Yahoo!, IBM, and more]]>http://www.bloggingstocks.com/2009/04/25/earnings-highlights-bank-of-america-amazon-coke-ebay-ups-y/http://www.bloggingstocks.com/2009/04/25/earnings-highlights-bank-of-america-amazon-coke-ebay-ups-y/http://www.bloggingstocks.com/2009/04/25/earnings-highlights-bank-of-america-amazon-coke-ebay-ups-y/#commentsFiled under: , , , , , , , , , , , , , ,

Here are some highlights from this past week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Bank of America, Amazon, Coke, eBay, UPS, Yahoo!, IBM, and more

Earnings highlights: Bank of America, Amazon, Coke, eBay, UPS, Yahoo!, IBM, and more originally appeared on BloggingStocks on Sat, 25 Apr 2009 15:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>3MAmazonAmgenAMGNAMZNBACBank of AmericaCATCaterpillarCoca-ColaearningseBayHASHasbroIBMJEFJeffries GroupJim CramerKOMerckMMMMorgan StanleyMRKMSPEPPepsicoRiverbedRVBDSchlumbergerSLBTXNUPSWeatherfordWFTYahooYHOOSat, 25 Apr 2009 15:40:00 EST<![CDATA[Closing Bell: Investors buy earnings rather than flee pay caps (CAT, GM, JEF, MRK, AMTD)]]>http://www.bloggingstocks.com/2009/04/21/closing-bell-investors-buy-earnings-rather-than-flee-pay-caps/http://www.bloggingstocks.com/2009/04/21/closing-bell-investors-buy-earnings-rather-than-flee-pay-caps/http://www.bloggingstocks.com/2009/04/21/closing-bell-investors-buy-earnings-rather-than-flee-pay-caps/#commentsFiled under: , , ,

Despite the notion that lawmakers are considering executive compensation pay caps for those companies which may invest in the $1 trillion PPIP, the markets did not turn against Pennsylvania Ave. There were not really any major economic data and shares bounced off lows after traders determined that the bar was being set very low.

Here are today's closing bell levels (unofficial close):

Dow 7,969.56 +127.83 (1.63%)
S&P 500 850.08 +17.69 (2.13%)
Nasdaq 1,643.85 +35.64 (2.22%)

TOP 10 ANALYST CALLS

Continue reading Closing Bell: Investors buy earnings rather than flee pay caps (CAT, GM, JEF, MRK, AMTD)

Closing Bell: Investors buy earnings rather than flee pay caps (CAT, GM, JEF, MRK, AMTD) originally appeared on BloggingStocks on Tue, 21 Apr 2009 16:15:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>JEFjeffries groupJeffriesGrouptd ameritradeTdAmeritradeTue, 21 Apr 2009 16:15:00 EST<![CDATA[Merck profit drops, company cuts revenue]]>http://www.bloggingstocks.com/2009/04/21/merck-profit-drops-company-cuts-revenue/http://www.bloggingstocks.com/2009/04/21/merck-profit-drops-company-cuts-revenue/http://www.bloggingstocks.com/2009/04/21/merck-profit-drops-company-cuts-revenue/#commentsFiled under: ,

This morning, Merck (NYSE: MRK) unveiled first-quarter earnings, which dropped 57% thanks to a drop in both drug sales and income from its cholesterol medicine partnerships. Excluding charges, Merck brought in 74 cents per share in quarterly earnings. The results were a full three cents short of the consensus estimate.

Turning to revenue, Merck reported $5.39 billion - an 8% drop from a year ago. The consensus estimate for quarterly revenue was $5.77 billion, so the results were far short of the bar set by the Street.

Continue reading Merck profit drops, company cuts revenue

Merck profit drops, company cuts revenue originally appeared on BloggingStocks on Tue, 21 Apr 2009 08:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>earnings disappointmentearnings reportEarningsDisappointmentEarningsReportinthenewsmedical developmentMedicalDevelopmentmedicinenew drugsNewDrugsTue, 21 Apr 2009 08:30:00 EST<![CDATA[Before the bell: Stocks set for yet another low start with a wave of earnings ahead]]>http://www.bloggingstocks.com/2009/04/21/before-the-bell-stocks-set-for-yet-another-low-start-with-a-wav/http://www.bloggingstocks.com/2009/04/21/before-the-bell-stocks-set-for-yet-another-low-start-with-a-wav/http://www.bloggingstocks.com/2009/04/21/before-the-bell-stocks-set-for-yet-another-low-start-with-a-wav/#commentsFiled under: , , , , , , , , , ,

U.S. stock futures fell Tuesday morning following Monday's sharp sell-off. Investors are reacting to Monday evening's earnings and bracing for another wave of corporate earnings today, including five Dow Jones Industrial Average stocks. Monday's sell-off highlighted Wall Street's worries over earnings generally and the financial sector in particular.

Five Dow components are set to report earnings before the bell: Caterpillar (NYSE: CAT), Coca-Cola (NYSE: KO), DuPont (NYSE: DD), Merck (NYSE: MRK) and United Technologies (NYSE: UTX).

Continue reading Before the bell: Stocks set for yet another low start with a wave of earnings ahead

Before the bell: Stocks set for yet another low start with a wave of earnings ahead originally appeared on BloggingStocks on Tue, 21 Apr 2009 07:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>Tue, 21 Apr 2009 07:30:00 EST<![CDATA[Should you invest in low priced biotech stocks like Dendreon?]]>http://www.bloggingstocks.com/2009/04/15/should-you-invest-in-low-priced-biotech-stocks-like-dendreon/http://www.bloggingstocks.com/2009/04/15/should-you-invest-in-low-priced-biotech-stocks-like-dendreon/http://www.bloggingstocks.com/2009/04/15/should-you-invest-in-low-priced-biotech-stocks-like-dendreon/#commentsFiled under: , , , , , ,

When a $7 a share biotechnology company like Dendreon Corp. (NASDAQ: DNDN) rockets 200% to over $20 a share in one day, like it did yesterday after reporting successful Phase 3 trials of its prostate cancer drug, investors get interested in any biotech stock under $10.

But before investing in these speculative companies, you should have a clear understanding of how this niche operates. Marketing plays an important role in order for the companies to raise capital, therefore if you are interested in betting on a company's future, you should consider the risk factors and odds of success.

Continue reading Should you invest in low priced biotech stocks like Dendreon?

Should you invest in low priced biotech stocks like Dendreon? originally appeared on BloggingStocks on Wed, 15 Apr 2009 12:45:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>amgnarnabiotechbiotech stocksbiotechnologyBiotechStocksdaleela farinaDaleelaFarinadndnfeaturedjnjmrkpgvphmWed, 15 Apr 2009 12:45:00 EST